You have 9 free searches left this month | to do more

entinostat

Entinostat is a drug used to treat Breast Cancer, Recurrent Adult Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, and other conditions. Entinostat is being actively studied in 19 studies and prior, has been studied in 25.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Johns Hopkins University/Sidney Kimmel Cancer CenterRoberto Pili
Syndax PharmaceuticalsRoswell Park Cancer InstituteAntonio Fojo
Roberto PiliMemorial Sloan Kettering Cancer CenterFatima Karzai, M.D.
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Neuroendocrine Tumors
  • Entinostat
  • New York, New York
    Columbia University Medical Center
2021-10-06
Oct 6, 2021
S
Completed
  • Metastatic Cholangiocarcinoma
  • +5 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2021-12-17
Dec 17, 2021
S
Completed
  • Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • Denver, Colorado
  • +2 more
2021-12-14
Dec 14, 2021
S
Completed
  • Lung Cancer
  • +3 more
  • entinostat
  • +2 more
  • Sarasota, Florida
  • +2 more
2021-11-11
Nov 11, 2021
R
Active, not recruiting
  • Renal Cell Carcinoma
  • Entinostat
  • +2 more
  • Washington, District of Columbia
  • +1 more
2022-01-10
Jan 10, 2022
R
Suspended
  • Metastatic Cancer
  • Renal Cancer
  • Indianapolis, Indiana
  • +3 more
2022-02-25
Feb 25, 2022
N
Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
U
Recruiting
  • Melanoma
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
2021-05-08
May 8, 2021
G
Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
2021-07-26
Jul 26, 2021
R
Active, not recruiting
  • Renal Cell Carcinoma
  • Los Angeles, California
  • +4 more
2022-02-14
Feb 14, 2022
A
Withdrawn
  • Pancreas Cancer
  • Entinostat
  • FOLFOX regimen
  • (no location specified)
2021-01-13
Jan 13, 2021
N
Not yet recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • (no location specified)
2022-03-30
Mar 30, 2022
A
Completed
  • Colorectal Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2020-12-16
Dec 16, 2020
M
Recruiting
  • Lymphoma
  • +2 more
  • Evanston, Illinois
  • +8 more
2022-03-09
Mar 9, 2022
V
S
Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
2022-01-24
Jan 24, 2022
U
Terminated
  • Breast Cancer
  • +2 more
  • Entinostat
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-03-22
Mar 22, 2021
N
Active, not recruiting
  • Male Breast Carcinoma
  • +4 more
  • Duarte, California
  • +6 more
2021-12-14
Dec 14, 2021
T
Active, not recruiting
  • Advanced Breast Cancer
  • Entinostat
  • +2 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy Medical Sciences
2021-07-07
Jul 7, 2021
U
Recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Rochester, New York
  • +1 more
2020-09-11
Sep 11, 2020
N
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
2021-02-09
Feb 9, 2021
N
U
Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
2021-12-20
Dec 20, 2021